Gimbal Financial Novartis Ag Transaction History
Gimbal Financial
- $122 Billion
- Q1 2024
A detailed history of Gimbal Financial transactions in Novartis Ag stock. As of the latest transaction made, Gimbal Financial holds 2,243 shares of NVS stock, worth $239,507. This represents 0.18% of its overall portfolio holdings.
Number of Shares
2,243
Previous 2,243
-0.0%
Holding current value
$239,507
Previous $226 Million
4.2%
% of portfolio
0.18%
Previous 0.23%
Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,349Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.33 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.32 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$775 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$643 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$632 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $230B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...